Literature DB >> 30497814

Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.

Marcus Fernando Kodama Pertille Ramos1, Marina Alessandra Pereira2, Andre Roncon Dias2, Osmar Kenji Yagi2, Evelise Pelegrinelli Zaidan2, Ulysses Ribeiro-Júnior2, Bruno Zilberstein2, Ivan Cecconello2.   

Abstract

BACKGROUND: Gastric cancer (GC) patients with advanced age and/or multiple morbidities have limited expected survival and may not benefit from extended lymph node resection. The aim of this study was to evaluate the surgical outcomes of these GC patients who underwent gastrectomy with D1 dissection.
METHODS: We retrospectively reviewed all GC patients who underwent gastrectomy with curative intent from 2009 to 2017. The decision to perform D1 was based on preoperative multidisciplinary meeting, and/or intraoperative clinical judgment.
RESULTS: Among 460 enrolled patients, 73 (15.9%) underwent D1 lymphadenectomy and 387 (84.1%) D2 lymphadenectomy. Male gender, older age, American Society of Anesthesiologists score (ASA) III/IV, higher neutrophil-to-lymphocyte ratio (NLR) and higher Charlson Comorbidity Index (CCI) were more common in the D1 group. Postoperative major complications were significantly higher in D1 group (24.7% vs 12.4%, p < 0.001) and mostly related to clinical complications. Locoregional recurrence was higher in the D1 group (53.8% vs 39.5%, p = 0.330) however, without statistical significance. No difference was found in disease-free survival (DFS) between D1 and D2 patients with positive lymph nodes (p = 0.192), whereas overall survival was longer in the D2 group (p < 0.001). Multivariate analysis showed a statistically significant impact on survival of age ≥70 years, CCI ≥5, total gastrectomy, D1 lymphadenectomy and advanced stages (III/IV).
CONCLUSIONS: Frail patients had high surgical mortality even when submitted to D1 dissection. DFS was comparable to D2. Extent of lymphadenectomy in high-risk patients should take in account the expectation of a decrease in surgical risk with the possibility of impairment of long-term survival.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Elderly; Frail; Lymph node excision; Postoperative complications; Stomach neoplasms

Mesh:

Year:  2018        PMID: 30497814     DOI: 10.1016/j.ejso.2018.11.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.

Authors:  V Rodrigues; F Landi; S Castro; R Mast; N Rodríguez; A Gantxegi; J Pradell; M López-Cano; M Armengol
Journal:  J Gastrointest Surg       Date:  2020-07-13       Impact factor: 3.452

2.  Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.

Authors:  Marina Alessandra Pereira; Marcus Fernando Kodama Pertille Ramos; André Roncon Dias; Sheila Friedrich Faraj; Renan Ribeiro E Ribeiro; Tiago Biachi de Castria; Bruno Zilberstein; Venancio Avancini Ferreira Alves; Ulysses Ribeiro; Evandro Sobroza de Mello
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

3.  Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients.

Authors:  Marcus Fernando Kodama Pertille Ramos; Tiago Biachi de Castria; Marina Alessandra Pereira; Andre Roncon Dias; Fernanda Fronzoni Antonacio; Bruno Zilberstein; Paulo Marcelo Gehm Hoff; Ulysses Ribeiro; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2019-11-19       Impact factor: 3.452

4.  Laparoscopic gastrectomy for early and advanced gastric cancer in a western center: a propensity score-matched analysis.

Authors:  Marcus Fernando Kodama Pertille Ramos; Marina Alessandra Pereira; André Roncon Dias; Ulysses Ribeiro; Bruno Zilberstein; Sergio Carlos Nahas
Journal:  Updates Surg       Date:  2021-06-04

5.  GASTRECTOMY IN OCTOGENARIANS WITH GASTRIC CANCER: IS IT FEASIBLE?

Authors:  Francisco Diogo Almeida Silva; Marina Alessandra Pereira; Marcus Fernando Kodama Pertille Ramos; Ulysses Ribeiro-Junior; Bruno Zilberstein; Ivan Cecconello; Andre Roncon Dias
Journal:  Arq Bras Cir Dig       Date:  2021-01-25

6.  The efficacy of treating patients with non-metastatic gastric linitis plastica using surgery with chemotherapy and/or radiotherapy.

Authors:  Xueru Song; Yan Shi; Tao Shi; Baorui Liu; Jia Wei; Jiping Wang
Journal:  Ann Transl Med       Date:  2020-11

7.  Impact of COVID-19 pandemic on the surgical treatment of gastric cancer.

Authors:  Amanda Juliani Arneiro; Marcus Fernando Kodama Pertille Ramos; Marina Alessandra Pereira; André Roncon Dias; Bruno Zilberstein; Ulysses Ribeiro Junior; Sergio Carlos Nahas
Journal:  Clinics (Sao Paulo)       Date:  2021-11-26       Impact factor: 2.365

8.  Surgical and oncological outcomes of distal gastrectomy compared to total gastrectomy for middle-third gastric cancer: A systematic review and meta-analysis.

Authors:  Yuxing Jiang; Fan Yang; Jingfu Ma; Ning Zhang; Chao Zhang; Gaoming Li; Zhengyan Li
Journal:  Oncol Lett       Date:  2022-07-04       Impact factor: 3.111

9.  A retrospective study comparing D1 limited lymph node dissection and D2 extended lymph node dissection for N3 gastric cancer.

Authors:  Xing Luo; Ming-Xiu Zhou; Wei Tian; Ming Zeng; Jian-Ling Xia; Gao-Ping Zhao; Hong-Lin Hu; Xin-Bao Hao; Liang-Fu Han; Hao Liu; Yang-Ke He; Xue-Qiang Zhu; Liang Liang; Min Wei; Li-Li Deng
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.